| Literature DB >> 30728620 |
Neo M Tapela1, Gontse Tshisimogo2, Bame P Shatera2, Virginia Letsatsi2, Moagi Gaborone3, Tebogo Madidimalo3, Martins Ovberedjo3, Haruna B Jibril2, Billy Tsima4, Oathokwa Nkomazana4, Scott Dryden-Peterson5, Shahin Lockman6, Tiny Masupe4, Lisa R Hirschhorn7, Shenaaz El Halabi8.
Abstract
Despite the rising burden of noncommunicable diseases, access to quality decentralized noncommunicable disease services remain limited in many low- and middle-income countries. Here we describe the strategies we employed to drive the process from adaptation to national endorsement and implementation of the 2016 Botswana primary healthcare guidelines for adults. The strategies included detailed multilevel assessment with broad stakeholder inputs and in-depth analysis of local data; leveraging academic partnerships; facilitating development of supporting policy instruments; and embedding noncommunicable disease guidelines within broader primary health-care guidelines in keeping with the health ministry strategic direction. At facility level, strategies included developing a multimethod training programme for health-care providers, leveraging on the experience of provision of human immunodeficiency virus care and engaging health-care implementers early in the process. Through the strategies employed, the country's first national primary health-care guidelines were endorsed in 2016 and a phased three-year implementation started in August 2017. In addition, provision of primary health-care delivery of noncommunicable disease services was included in the country's 11th national development plan (2017-2023). During the guideline development process, we learnt that strong interdisciplinary skills in communication, organization, coalition building and systems thinking, and technical grasp of best-practices in low- and middle-income countries were important. Furthermore, misaligned agendas of stakeholders, exaggerated by a siloed approach to guideline development, underestimation of the importance of having policy instruments in place and coordination of the processes initially being led outside the health ministry caused delays. Our experience is relevant to other countries interested in developing and implementing guidelines for evidence-based noncommunicable disease services.Entities:
Mesh:
Year: 2019 PMID: 30728620 PMCID: PMC6357568 DOI: 10.2471/BLT.18.221424
Source DB: PubMed Journal: Bull World Health Organ ISSN: 0042-9686 Impact factor: 9.408
Prevalence of noncommunicable disease risk factors among adults aged 15–69 years, Botswana, 2014
| Risk factor | All ( | Male ( | Female ( | |||||
|---|---|---|---|---|---|---|---|---|
| No.a | Weighted % (95% CI) | No.a | Weighted % (95% CI) | No.a | Weighted % (95% CI) | |||
| % of people who currently smoke tobacco | 4066 | 18.3 (15.9–20.7) | 1316 | 31.4 (27.5–35.3) | 2750 | 4.9(3.5–6.2) | ||
| % of people with insufficient fruit or vegetable consumptionb | 3651 | 94.8 (93.4–96.1) | 1161 | 95.8 (93.9–97.6) | 2490 | 93.8 (92.2–95.4) | ||
| % of people with insufficient physical activityc | 3671 | 20.1 (17.4–22.7) | 1182 | 14.3 (11.3–17.3) | 2489 | 25.9 (22.7–29.2) | ||
| % of people who are overweight or obesed | 3906 | 30.6 (28.5–32.7) | 1299 | 19.8 (17.0–22.6) | 2607 | 42.3 (39.5–45.0) | ||
| % of people with hypertensione | 4056 | 29.4 (27.3–31.6) | 1314 | 30.4 (27.2–33.7) | 2742 | 28.4 (25.9–30.8) | ||
| % of people with elevated fasting glucose level or currently on treatment for diabetesf | 3481 | 4.5 (3.3–5.7) | 1115 | 3.3 (2.2–4.9) | 2366 | 4.8 (3.6–6.1) | ||
| % of people who are aged 40–69 years and have a 10-year CVD risk of ≥ 30% or an existing CVDg | 3468 | 9.7 (6.9–12.6) | 1113 | 9.3 (5.2–13.5) | 2355 | 10.1 (6.7–13.4) | ||
CI: confidence interval; CVD: cardiovascular disease.
a Denominator of proportion is reported.
b More than five servings of fruit and/or vegetables on average per day.
c Less than 150 minutes of moderate-intensity activity per week.
d Definitions of overweight and obesity are a body mass index of ≥ 25.0 kg/m2 and ≥ 30.0 kg/m2, respectively.
e People with systolic blood pressure ≥ 140 and/or diastolic blood pressure ≥ 90 mmHg or currently on hypertensive medication.
f Elevated glucose level is defined as a concentration of ≥ 7.0 mmol/L in venous blood.
g A 10-year CVD risk of ≥ 30% is defined according to age, sex, blood pressure, smoking status (smoker defined as current smokers or those who quit smoking less than 1 year before the assessment), total cholesterol and diabetes previously diagnosed or a fasting plasma glucose concentration > 7.0 mmol/L.
Data source: Botswana STEPS survey report on non-communicable disease risk factors.
Fig. 1Strategies employed in facilitating endorsement and initial implementation of Botswana’s national primary care guidelines, 2014–2017
Observed quality of follow up care for hypertensive patients, Botswana, 2015
| Service component | No. of patients (%) |
|---|---|
| With comorbid diabetes | 16 (20) |
| With other noncommunicable disease comorbidities | 9 (11) |
| Asked about symptoms | 78 (95) |
| Asked about hospitalization interval | 1 (1) |
| Measured blood pressure | 82 (100) |
| Used correct blood pressure measurement technique | 66 (80) |
| Measured weight | 24 (29) |
| Measured height | 0 (0) |
| Measured waist circumference | 0 (0) |
| Performed foot exam | 11 (13) |
| Asked about medication adherence | 47 (57) |
| Appropriately increased antihypertensive medication | 59 (72) |
| Ordered appropriate laboratory tests | 22 (27) |
| Scheduled appropriate follow-up | 65 (79) |
| Provided education on disease danger signs | 4 (5) |
| Advised about physical activity | 14 (17) |
| Advised about healthy diet | 36 (44) |
| Advised about alcohol consumption | 4 (5) |
| Advised about tobacco use | 2 (2) |
| Provided any advice on lifestyle modification | 27 (33) |
Outline of the essential noncommunicable disease package included in the 2016 Botswana’s primary health-care guidelines for adults
| Service componentsa | Service task examples | Provider of service |
|---|---|---|
| Education and self-management support | Advise individuals or groups on lifestyle modification, smoking cessation, by employing the five A’s: ask; advise; assess; assist; and arrange | Nurse at primary clinic or dieticianb |
| Screening and risk stratification for people older than 40 years | Ask about lifestyle risk factors, including tobacco; harmful alcohol use; diet and physical activity; family history; past medical history; and symptoms related to diabetes, hypertension, heart disease and chronic respiratory disease | Nurse at primary clinic |
| Assess age, sex, HIV status, BMI or waist circumference, blood pressure, fasting or random glucose level and total cholesterol level for patients with more than two other risk factors | Nurse at primary clinic | |
| Screening women for cervical and breast cancer | Do pap smear or VIA for females aged 30–49 years and physical breast exam for females aged 40–69 years | Nurse or midwife at primary clinic, VIA performed at district hospital by nurse or midwife |
| Triage and emergent referral | Assess the criteria for emergent status, such as systolic blood pressure above 200, unstable angina, acute stroke or diabetic ketoacidosis | Nurse at primary clinic, in consultation with nurseb or doctorb |
| Risk-based treatment | For patients with hypertension: initiate antihypertensive if blood pressure is persistently above 140/90; | Nurse at primary clinic, with initial review by rotating doctord |
| Assess 10-year CVD riskc | Nurse at primary clinic | |
| For patients with a CVD risk of 10–20%, suggest lifestyle modifications | Nurse at primary clinic | |
| For patients with a CVD risk of 20–30%, suggest lifestyle modifications and prescribe statins | Nurse at primary clinic, with initial review by rotating doctord | |
| For patients with a CVD risk above 30%, suggest lifestyle modifications and prescribe statins and aspirin | Nurse at primary clinic, with initial review by rotating doctord | |
| Refer patients who have uncontrolled disease despite primary clinic management (e.g. blood pressure > 140/90 despite three antihypertensive medications) to district hospital | Nurse at primary clinic | |
| Delivery system design | Trace missed visits and conduct home visits | Nurse at primary clinic, supported by community nurse or social workerb |
| Provide care coordination support for patients requiring care across facility levels | Community nurseb | |
| Decision support | Train and coach nurses at primary clinics | Master trainer team |
ACE: angiotensin-converting-enzyme; BMI: body mass index; CVD: cardiovascular disease; HIV: human immunodeficiency virus; VIA: visual inspection with acetic acid.
a Service components supported by systematic monitoring and evaluation of care, provider training and mentorship, availability of essential medicines and diagnostics.
b Members of the multidisciplinary master trainer team.
c CVD risk is assessed according to age, sex, blood pressure, smoking status (smoker defined as current smokers or those who quit smoking less than 1 year before the assessment), total cholesterol level and diabetes.
d General practitioner seeing patients at district hospital or conducting outreach visits to primary clinics.
Key noncommunicable disease performance indicators for Botswana's national primary health-care guidelines implementation
| District-level indicator by implementation outcomea | Target |
|---|---|
| % of facilities with ≥ 2 providers trained | > 90% |
| % of facilities with ≥ 2 consecutive monthly reports submitted to district monitoring and evaluation team | > 90% |
| % increase in individuals enrolled in care, compared with baselineb | > 10% |
| Coverage of blood pressure screening among residents older than 40 years | > 10% |
| Coverage of cervical cancer screening among female residents aged 30–49 years | > 10% |
| Coverage of screening for breast cancer by physical exam, among female residents aged 40–69 years | > 10% |
| % of new visits by patients aged 40 years or older where CVD risk is assessed and documentedc | > 90% |
| % of new visits where patients with 10-year CVD risk above 30% is started on statin | > 90% |
| % all visits where patients with blood pressure above 160/100 antihypertensives are increased | > 90% |
| % people with hypertension with most recent blood pressure < 140/90 mmHg (among enrolled patients with a visit during the previous month) | > 60%d |
| Mean change in systolic blood pressure over the past 12 months for people with hypertension | −5mmHgd |
| % of people with diabetes with most recent glucose or HbA1c level < 8 mmol/L and above 6.5 mmol/L (among enrolled diabetics with a visit during the previous month) | > 60%d |
| % patients enrolled in careb with at least one visit in addition to intake visit (retention) | > 90% |
BMI: body mass index; CVD: cardiovascular disease: HbA1c: glycated haemoglobin.
a Indicators are based on RE-AIM framework, which assesses five domains: reach; efficacy; adoption; implementation and maintenance, WHO HEARTS technical tool and Partners In Health Guide to Chronic care integration of endemic noncommunicable diseases.
b Patients enrolled in care at baseline are individuals who had at least one visit during the 12 months period before guidelines implementation, were not known to have died or relocated and who meet any of the following criteria: known hypertension or diabetes, older than 40 years, or a 10-year CVD risk above 10%. New patients are those with same clinical criteria as above, enrolled in care during the 12 months following guidelines implementation within the given district
c CVD risk assessment deemed completed if the provider had checked and documented: age, sex, blood pressure, blood glucose level, BMI or waist circumference, tobacco use and human immunodeficiency virus status.
d The target consists of two categories: (i) new diagnosis, patients diagnosed within the past 12 months; and (ii) knowing diagnosis, patients diagnosed over 12 months before end of reporting period.
Notes: Targets to be achieved within 12 months of guidelines implementation start. Facilities submit reports monthly including patient-level data, data are then aggregated across districts and nationally reviewed on quarterly and annual basis. Data will be augmented by periodic purposive audits.
Key strategies employed in response to contextual factors during adoption and initial implementation of Botswana primary health-care guidelines
| Key implementation strategies by implementation phasea | Contextual factors |
|---|---|
| Multilevel assessment to understand sociopolitical landscape, funding, current clinical practice and strategic priorities. Used broad stakeholder inputs; review of policies, legislation, programme reports, local data analysis, and operational research | Concerns that noncommunicable diseases might reverse health gains made when combatting HIV.b Existing national noncommunicable disease programme to spearhead effortb |
| Assessed facility capacity and readiness to deliver quality services at primary health-care level. Used purposive sampling and local university trainees to general local data at lower cost | Constrained resources for rigorous facility and provider and/or client assessment |
| In-depth analysis of local data, leveraged partnerships with academic institutions | Limited research evidence interpretation and analytical expertise within the health ministry; data available from the 2014 noncommunicable disease risk factors surveyb |
| Selected and adapted guidelines that fit model of care aligned with health ministry structure and strategic direction. Embedded noncommunicable diseases within primary health-care guidelines, aligning with the health ministry strategic direction and emphasizing integrated primary health-care services for individuals with multiple risk factors and morbidities | Key policy instruments did not exist before 2016; the global advocacy for UHC; the health ministry’s primary care-oriented strategic directionb |
| Engaged future on-the-ground adopters early on, starting with guidelines adaptation, to ensure context appropriate guidelines and facilitate ownership and sustainment | Before these guidelines, the experience and focus of health-care providers was predominantly HIV-focused, thus challenging adoption |
| Set up a broad technical working group and leveraged intersectoral forums to advocate for national prioritization of noncommunicable diseases and enable development of supportive policy instruments, such as a noncommunicable disease strategic plan, national essential medicines list and a national development plan | Tradition of siloed, disease and/or programme-focused approach to guidelines development |
| Achieved strong and streamlined stakeholder coordination to minimize fatigue and redundancy, through multiple nonlinear related processesc | The small pool of local technical experts presenting risk of meeting fatigue |
| Started implementation in districts with some experience in multidisciplinary chronic disease management | Hospital-based multidisciplinary diabetes clinics established in 2012 in eight districtsb |
| Coupled standardized in-serve training programme with long-term mentorship to support continued change in practice | Positive and recent experience with HIV training programme, using master trainersb |
| Monitored standardized performance indicators,d which include process measures to signal early on delayed progress and suggest solutions to address delays | No existing routine reporting of noncommunicable diseases care; cumbersome paper-based reporting |
| Established public–private partnership to provide technical expertise and expediently obtain funding for initial training | Absence of global funding mechanism for noncommunicable diseases; slow government budget allocation processes |
| Included noncommunicable diseases mortality reduction priority and strategies in the next national development plan. Selected indicators included in health ministry’s key performance indcators | 10th National Development Plan ending in 2016b |
| Developed experienced local master trainers and non-proprietary training material to allow for future trainings without need for external resources | Recent and positive experience with national HIV training programmeb |
| Going forward, will explore future electronic monitoring of primary health-care indicators, and regular feedback to providers, which will be critical to ensuring continued high-quality surveillance data | Existing patient-level electronic health information primarily for HIV, tuberculosis and child health |
HIV: human immunodeficiency virus; UHC: universal health coverage.
a We used a multilevel model that divides the implementation process into four phases: exploration, preparation, implementation and sustainment.
b Enabling contextual factors.
c Nonlinear related processes were noncommunicable disease strategy development, review of essential medicines list, development of primary care guidelines
d We defined the indicators according to the RE-AIM framework.